FTSV
Forty Seven, Inc.

754
Loading...
Loading...
Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Forty Seven Inc?
What is the 52-week high for Forty Seven Inc?
What is the 52-week low for Forty Seven Inc?
What was Forty Seven Inc stock price yesterday?
What is the PE ratio of Forty Seven Inc?
What is the Price-to-Book ratio of Forty Seven Inc?
What is the 50-day moving average of Forty Seven Inc?

Latest FTSV News

View
No FTSV news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.